MC2203A1 - Medicament contre la cryptosporidiose - Google Patents

Medicament contre la cryptosporidiose

Info

Publication number
MC2203A1
MC2203A1 MC891287D MC1287D MC2203A1 MC 2203 A1 MC2203 A1 MC 2203A1 MC 891287 D MC891287 D MC 891287D MC 1287 D MC1287 D MC 1287D MC 2203 A1 MC2203 A1 MC 2203A1
Authority
MC
Monaco
Prior art keywords
cryptosporidiosis
prophylaxis
cryptosporidiasis
medicine
animal
Prior art date
Application number
MC891287D
Other languages
English (en)
Inventor
Victoria Susan Latter
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MC2203A1 publication Critical patent/MC2203A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MC891287D 1989-10-16 1989-10-26 Medicament contre la cryptosporidiose MC2203A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898923254A GB8923254D0 (en) 1989-10-16 1989-10-16 Medicaments

Publications (1)

Publication Number Publication Date
MC2203A1 true MC2203A1 (fr) 1992-11-26

Family

ID=10664644

Family Applications (1)

Application Number Title Priority Date Filing Date
MC891287D MC2203A1 (fr) 1989-10-16 1989-10-26 Medicament contre la cryptosporidiose

Country Status (14)

Country Link
EP (1) EP0496729B1 (fr)
JP (1) JPH05502435A (fr)
KR (1) KR920703038A (fr)
AT (1) ATE107504T1 (fr)
AU (1) AU637772B2 (fr)
CA (1) CA2001566A1 (fr)
DE (1) DE68916443T2 (fr)
DK (1) DK50092A (fr)
GB (1) GB8923254D0 (fr)
HU (1) HU208625B (fr)
IE (1) IE893450A1 (fr)
MC (1) MC2203A1 (fr)
WO (1) WO1991005550A1 (fr)
ZA (1) ZA898143B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9126874D0 (en) * 1991-12-18 1992-02-19 Wellcome Found Medicaments
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
GB9613309D0 (en) * 1996-06-25 1996-08-28 Univ Sheffield Quinone bacterial inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives

Also Published As

Publication number Publication date
DK50092D0 (da) 1992-04-14
EP0496729A1 (fr) 1992-08-05
DE68916443T2 (de) 1994-12-22
HU9201295D0 (en) 1992-07-28
EP0496729B1 (fr) 1994-06-22
AU637772B2 (en) 1993-06-10
WO1991005550A1 (fr) 1991-05-02
JPH05502435A (ja) 1993-04-28
IE893450A1 (en) 1991-04-24
ZA898143B (en) 1991-06-26
DK50092A (da) 1992-04-14
DE68916443D1 (de) 1994-07-28
GB8923254D0 (en) 1989-12-06
AU4519289A (en) 1991-05-16
CA2001566A1 (fr) 1991-04-16
ATE107504T1 (de) 1994-07-15
KR920703038A (ko) 1992-12-17
HUT60431A (en) 1992-09-28
HU208625B (en) 1993-12-28

Similar Documents

Publication Publication Date Title
ATE515265T1 (de) Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen
IT1241997B (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
ATE179888T1 (de) Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
ATE198550T1 (de) Verwendung von weihrauch zur behandlung der alzheimer-krankheit
NO912414L (no) Forbindelse med mavesyreinhiberende effekt og fremgangsmaate for dens fremstilling.
MC2142A1 (fr) Medicament contre la toxoplasmose
MC2203A1 (fr) Medicament contre la cryptosporidiose
ES2105643T3 (es) Uso de la 2-(4-(4-clorofenil)ciclohexil)-3-hidroxi-1,4-naftoquinona para el tratamiento del cancer.
BR9612316A (pt) Agente para profilaxia e tratamento de complicações diabéticas
RU98101105A (ru) Новое применение в медицинских целях
GB9126874D0 (en) Medicaments
GEP19970834B (en) 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
RU2011380C1 (ru) Способ профилактики и лечения некробактериоза животных
IL110888A (en) Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound
KR890000089A (ko) 신장 질환 치료제